Status of APOBEC3G/F in cells and progeny virions modulated by Vif determines HIV-1 infectivity

Microbes and Infection

Volumn 12, Issue 2, 2010, Pages 166-171

  Yamashita, Tomoki ^a   Nomaguchi, Masako ^a   Miyake, Ariko ^a   Uchiyama, Tsuneo ^a   Adachi, Akio ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

APOBEC3F; APOBEC3G; HIV 1; Vif; Virion incorporation

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3F; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; MUTANT PROTEIN; VIF PROTEIN;

ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOBLOTTING; IMMUNOPRECIPITATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGENY; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; VIRION; VIRUS INFECTIVITY; VIRUS REPLICATION;

CELL LINE; CYTIDINE DEAMINASE; CYTOSINE DEAMINASE; HIV-1; HUMANS; MUTATION; VIF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; VIRION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 75149172243     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2009.11.007     Document Type: Article

References (23)

1. Holmes R.K., Malim M.H., and Bishop K.N. APOBEC-mediated viral restriction: not simply editing?. Trends Biochem. Sci. 32 (2007) 118-128
2. He Z., Zhang W., Chen G., Xu R., and Yu X.-F. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction. J. Mol. Biol. 381 (2008) 1000-1011
3. Yamashita T., Kamada K., Hatcho K., Adachi A., and Nomaguchi M. Identification of amino acid residues in HIV-1 Vif critical for binding and exclusion of APOBEC3G/F. Microbes Infect. 10 (2008) 1142-1149
4. Tian C., Yu X., Zhang W., Wang T., Xu R., and Yu X.F. Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F. J. Virol. 80 (2006) 3112-3115
5. Russel R.A., and Pathak V.K. Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F. J. Virol. 81 (2007) 8201-8210
6. Mehle A., Wilson H., Zhang C., Brazier A.J., McPike M., Pery E., and Gabuzda D. Identification of an APOBEC3G binding site in human immunodeficiency virus type 1 Vif and inhibitors of Vif-APOBEC3G binding. J. Virol. 81 (2007) 13235-13241
7. Pery E., Rajendran K., Brazier A.J., and Gabuzda D. Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm Vif. J. Virol. 83 (2009) 2374-2381
8. Dang Y., Wang X., Zhou T., York I.A., and Zheng Y.-H. Identification of a novel WxSLVK motif in the N terminus of human immunodeficiency virus and simian immunodeficiency virus Vif that is critical for APOBEC3G and APOBEC3F neutralization. J. Virol. 83 (2009) 8544-8552
9. Chen G., He Z., Wang T., Xu R., and Yu X.-F. A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G. J. Virol. 83 (2009) 8674-8682
10. Yu Y., Xiao Z., Ehrlich E.S., Yu X., and Yu F. Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines. Genes Dev. 18 (2004) 2867-2872
11. Luo K., Xiao Z., Ehrlich E., Yu Y., Liu B., Zheng S., and Yu X.F. Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G. Proc Natl Acad Sci U S A 102 (2005) 11444-11449
12. Mehle A., Thomas E.R., Rajendran K.S., and Gabuzda D. A zinc-binding region in Vif binds Cul5 and determines cullin selection. J. Biol. Chem. 281 (2006) 17259-17265
13. Xiao Z., Ehrlich E., Yu Y., Luo K., Wang T., Tian C., and Yu X.F. Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zinc-binding domain-stabilized hydrophobic interface in Vif. Virology 349 (2006) 290-299
14. Stopak K., de Noronha C., Yonemoto W., and Green W.C. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol. Cell 12 (2003) 591-601
15. Yu X., Yu Y., Liu B., Luo K., Kong W., Mao P., and Yu X.-F. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302 (2003) 1056-1060
16. Marin M., Rose K., Kozak S.L., and Kabat D. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat. Med. 9 (2003) 1398-1403
17. Sheehy A.M., Gaddis N.C., and Malim M.H. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif, Nat. Med 9 (2003) 1404-1407
18. Lebkowski J.S., Clancy S., and Calos M.P. Simian virus 40 replication in adenovirus-transformed human cells antagonizes gene expression. Nature 317 (1985) 169-171
19. Kimpton J., and Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virol. 66 (1992) 2232-2239
20. Adachi A., Gendelman H.E., Koenig S., Folks T., Willey R., Rabson A., and Martin M.A. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59 (1986) 284-291
21. Akari H., Fukumori T., and Adachi A. Cell-dependent requirement of human immunodeficiency virus type 1 gp41 cytoplasmic tail for Env incorporation into virions. J. Virol. 74 (2000) 4891-4893
22. Sova P., Volsky D.J., Wang L., and Chao W. Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed Gag. J. Virol. 75 (2001) 5504-5517
23. Khan M.A., Aberham C., Kao S., Akari H., Gorelick R., Bour S., and Strebel K. Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA. J. Virol. 75 (2001) 7252-7265